Already a member? Sign in
Tacrolimus (FK506) is an immunosuppressant agent. Taken orally or by injection it is used to prevent organ rejection in heart, kidney, or liver transplant recipients. Used as a topical skin product it is used for moderate-to-severe atopic dermatitis.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Prevent organ rejection | 524 | 28 |
|
|
|
|
|
| Transplant rejection prevention | 362 | 80 |
|
|
|
|
|
| Transplant rejection | 24 | 5 |
|
|
|
||
| Kidney Transplant | 21 | 6 |
|
|
|
|
|
| Kidney Transplant | 20 | 8 |
|
|
|||
| Liver transplant | 15 | 2 |
|
|
See all 1013 patients currently taking Tacrolimus
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Tacrolimus
| Tremor in hands | 24 | |
|---|---|---|
| Hair loss | 18 | |
| Hair thinning | 10 | |
| Shakiness | 8 | |
| Fatigue | 7 | |
| Shaky hands | 6 | |
| See all 112 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Tacrolimus. See all 85 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 15 | ||
| Doctor's advice | 12 | ||
| Other | 6 | ||
| Did not seem to work | 5 | ||
| Course of treatment ended | 4 | ||
| Change in health plan coverage | 3 | ||
| Expense | 2 | ||
| Not indicated | 1 |
Adherence
Taking treatment as prescribed
Adherence of Tacrolimus
Always |
120 | 94% |
|
|---|---|---|---|
Usually |
5 | 4% |
|
Sometimes |
0 | 0% |
|
Never |
2 | 2% |
|
Burden
Difficulty being on treatment
Burden of Tacrolimus
Very |
4 | 3% |
|
|---|---|---|---|
Somewhat |
4 | 3% |
|
A little |
14 | 11% |
|
Not at all |
105 | 83% |
|
Cost
Paid out of pocket
Cost of Tacrolimus
$200+ |
6 | 7% |
|
|---|---|---|---|
$100-199 |
7 | 8% |
|
$50-99 |
8 | 9% |
|
$25-49 |
7 | 8% |
|
< $25 |
58 | 67% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 23, 2012.